CHMI Q1 2026 Earnings EPS Surpasses Estimates Stock Advances IBRX Q1 2026 Earnings EPS Miss as Biotech Continues PreRevenue Advancement Adial Pharmaceuticals ADIL Q1 2026 Earnings NarrowerThanExpected Loss as Operational Progress Continues BCRX Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction CCSI Q1 2026 Earnings Strong EPS Beat Amidst Cautious Outlook TONX Q1 2026 Earnings EPS Surprise of 9655 Drives 62 Stock Gains Despite No Reported Revenue